Global Digital Biomarkers Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

List of Tables

The global demand for Digital Biomarkers Market is presumed to reach the market size of nearly USD 19.48 BN by 2030 from USD 3.6 BN in 2022 with a CAGR of 23.5% under the study period 2023 - 2030.

Digital biomarkers refer to measurable and quantifiable health-related data collected through digital devices and technologies, including wearables, smartphones, sensors, and other connected tools. These data points are used to monitor and analyze various aspects of an individual's health and behaviour in real time. These biomarkers provide valuable insights into a person's physiological, psychological, and behavioural patterns, enabling healthcare professionals and researchers to obtain a more holistic understanding of their well-being.

MARKET DYNAMICS:

The Digital biomarkers market is experiencing robust growth due to a combination of factors propelling the integration of technology into healthcare. Advancements in wearable devices, remote monitoring, and data analytics enable the collection of real-time health data, forming the basis for digital biomarkers. These biomarkers facilitate personalized healthcare, preventive approaches, and early detection of health issues. The wide adoption of smartphones, coupled with an ageing population and rising chronic diseases, fuels the demand for remote monitoring solutions. These biomarkers also find utility in mental health monitoring and clinical trials, while regulatory support and consumer awareness further drive their adoption. Nonetheless, challenges like data privacy and accuracy necessitate attention. The convergence of technology, healthcare needs, and patient empowerment underpins the expanding Digital biomarkers market, revolutionizing healthcare delivery and research methodologies.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of digital biomarkers. The growth and trends of digital biomarkers industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the digital biomarkers market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Wearable
Mobile Based Applications
Sensors
Others

By Clinical Practice

Diagnostic Digital Biomarkers
Monitoring Digital Biomarkers
Predictive And Prognostic Digital Biomarkers
Other'S (Safety, Pharmaco Dynamics/ Response, Susceptibility)

By Therapeutic Area

Cardiovascular And Metabolic Disorders (CVMD)
Respiratory Disorders
Psychiatric Disorders
Sleep & Movement Disease
Neurological Disorders
Musculoskeletal Disorders
Others (Diabetes, Pain Management)

By End-Use

Healthcare Companies
Healthcare Providers
Payers
Others (Patient, Caregivers)

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Digital Biomarkers market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Digital Biomarkers market include ActiGraph LLC, AliveCor Inc., Koneksa, Altoida Inc., Amgen Inc., Biogen Inc., Empatica Inc., Vivo Sense, IXICO plc, Adherium Limited, Neurotrack Technologies, Inc., Aural Analytic, Huma, Sonde Health, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112111961

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . DIGITAL BIOMARKERS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Clinical Practice
- 3.7.3 Market Attractiveness Analysis By Therapeutic Area
- 3.7.4 Market Attractiveness Analysis By End-Use
- 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY TYPE

5.1 Overview by Type
5.2 Historical and Forecast Data
5.3 Analysis by Type
5.4 Wearable Historic and Forecast Sales by Regions
5.5 Mobile Based Applications Historic and Forecast Sales by Regions
5.6 Sensors Historic and Forecast Sales by Regions
5.7 Others Historic and Forecast Sales by Regions

6 . GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY CLINICAL PRACTICE

6.1 Overview by Clinical Practice
6.2 Historical and Forecast Data
6.3 Analysis by Clinical Practice
6.4 Diagnostic Digital Biomarkers Historic and Forecast Sales by Regions
6.5 Monitoring Digital Biomarkers Historic and Forecast Sales by Regions
6.6 Predictive And Prognostic Digital Biomarkers Historic and Forecast Sales by Regions
6.7 Other's (Safety, Pharmaco Dynamics/ Response, Susceptibility) Historic and Forecast Sales by Regions

7 . GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY THERAPEUTIC AREA

7.1 Overview by Therapeutic Area
7.2 Historical and Forecast Data
7.3 Analysis by Therapeutic Area
7.4 Cardiovascular And Metabolic Disorders (CVMD) Historic and Forecast Sales by Regions
7.5 Respiratory Disorders Historic and Forecast Sales by Regions
7.6 Psychiatric Disorders Historic and Forecast Sales by Regions
7.7 Sleep & Movement Disease Historic and Forecast Sales by Regions
7.8 Neurological Disorders Historic and Forecast Sales by Regions
7.9 Musculoskeletal Disorders Historic and Forecast Sales by Regions
7.10. Others (Diabetes, Pain Management) Historic and Forecast Sales by Regions

8 . GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY END-USE

8.1 Overview by End-Use
8.2 Historical and Forecast Data
8.3 Analysis by End-Use
8.4 Healthcare Companies Historic and Forecast Sales by Regions
8.5 Healthcare Providers Historic and Forecast Sales by Regions
8.6 Payers Historic and Forecast Sales by Regions
8.7 Others (Patient, Caregivers) Historic and Forecast Sales by Regions

9 . GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Data Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Data Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Data Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. South East Asia Sales Analysis
- 9.5.10. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Data Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Data Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE DIGITAL BIOMARKERS COMPANIES

10.1. Digital Biomarkers Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF DIGITAL BIOMARKERS INDUSTRY

11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. ActiGraph LLC
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. AliveCor Inc.
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Koneksa
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Altoida Inc.
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Amgen Inc.
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Biogen Inc.
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Empatica Inc.
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Vivo Sense
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. IXICO plc
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. Adherium Limited
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments
11.13. Neurotrack Technologies Inc.
- 11.13.1. Company Overview
- 11.13.2. Company Revenue
- 11.13.3. Products
- 11.13.4. Recent Developments
11.14. Aural Analytic
- 11.14.1. Company Overview
- 11.14.2. Company Revenue
- 11.14.3. Products
- 11.14.4. Recent Developments
11.15. Huma
- 11.15.1. Company Overview
- 11.15.2. Company Revenue
- 11.15.3. Products
- 11.15.4. Recent Developments
11.16. Sonde Health Inc.
- 11.16.1. Company Overview
- 11.16.2. Company Revenue
- 11.16.3. Products
- 11.16.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies